Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)

BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
Long-term Extension, Multicentre, Multi-national Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg,1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Omaha, NE
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
Long-term Extension, Multicentre, Multi-national Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg,1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
Long-term Extension, Multicentre, Multi-national Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg,1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Cleveland, OH
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
Long-term Extension, Multicentre, Multi-national Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg,1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
Long-term Extension, Multicentre, Multi-national Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg,1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Columbus, OH
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
Long-term Extension, Multicentre, Multi-national Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg,1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
Long-term Extension, Multicentre, Multi-national Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg,1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Fairfield, OH
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
Long-term Extension, Multicentre, Multi-national Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg,1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fairfield, OH
Click here to add this to my saved trials
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
Long-term Extension, Multicentre, Multi-national Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg,1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
Long-term Extension, Multicentre, Multi-national Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg,1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
Long-term Extension, Multicentre, Multi-national Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg,1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
El Paso, TX
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
Long-term Extension, Multicentre, Multi-national Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg,1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
El Paso, TX
Click here to add this to my saved trials
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
Long-term Extension, Multicentre, Multi-national Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg,1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  12/31/1969
Investigational Site Number 032001
mi
from
Capital Federal,
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
Long-term Extension, Multicentre, Multi-national Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg,1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 12/31/1969
Investigational Site Number 032001
mi
from
Capital Federal,
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
Stanford University
mi
from
Palo Alto, CA
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
Yale University
mi
from
New Haven, CT
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
Emory University
mi
from
Atlanta, GA
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
Indiana University
mi
from
Indianapolis, IN
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
University of Iowa
mi
from
Iowa City, IA
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
Wayne State University
mi
from
Detroit, MI
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
University of New Mexico
mi
from
Albuquerque, NM
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
RTI International
mi
from
Durham, NC
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
RTI International
mi
from
Durham, NC
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
Duke University
mi
from
Durham, NC
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Medical Center
mi
from
Cincinnati, OH
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
Case Western Reserve Univ
mi
from
Cleveland, OH
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
Brown University, Women & Infants Hospital of Rhode Island
mi
from
Providence, RI
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
Brown University, Women & Infants Hospital of Rhode Island
mi
from
Providence, RI
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
UT Southwestern Medical Center
mi
from
Dallas, TX
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
La Jolla, CA
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Sacramento, CA
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Iowa City, IA
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Iowa City, IA
Click here to add this to my saved trials
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Baltimore, MD
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Boston, MA
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Cleveland, OH
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Columbus, OH
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated:  12/31/1969
mi
from
Corrientes,
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated: 12/31/1969
mi
from
Corrientes,
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Arizona Pulmonary Specialist
mi
from
Phoenix, AZ
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Arizona Pulmonary Specialist
mi
from
Phoenix, AZ
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Phoenix
mi
from
Phoenix, AZ
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Phoenix
mi
from
Phoenix, AZ
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
University of California San Francisco-Fresno
mi
from
Fresno, CA
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
University of California San Francisco-Fresno
mi
from
Fresno, CA
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
West Los Angeles VA Healthcare Center
mi
from
Los Angeles, CA
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
West Los Angeles VA Healthcare Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
UC Davis Medical Center
mi
from
Sacramento, CA
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
UC Davis Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
UCSD Medical Center
mi
from
San Diego, CA
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
UCSD Medical Center
mi
from
San Diego, CA
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Stanford University, Pulmonary and Critical Care
mi
from
Stanford, CA
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Stanford University, Pulmonary and Critical Care
mi
from
Stanford, CA
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Harbor UCLA Medical Center
mi
from
Torrance, CA
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Harbor UCLA Medical Center
mi
from
Torrance, CA
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Pulmonary Hypertension Clinic
mi
from
Aurora, CO
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Pulmonary Hypertension Clinic
mi
from
Aurora, CO
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
University of Florida - Jacksonville
mi
from
Jacksonville, FL
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
University of Florida - Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Florida
mi
from
Weston, FL
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Florida
mi
from
Weston, FL
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Emory University School of Medicine
mi
from
Atlanta, GA
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Emory University School of Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
University of Chicago
mi
from
Chicago, IL
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
University of Iowa Health Care
mi
from
Iowa City, IA
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
University of Iowa Health Care
mi
from
Iowa City, IA
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Kentuckiana Pulmonary Associates
mi
from
Louisville, KY
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Kentuckiana Pulmonary Associates
mi
from
Louisville, KY
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Alexandria Cardiology Clinic
mi
from
Alexandria, LA
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Alexandria Cardiology Clinic
mi
from
Alexandria, LA
Click here to add this to my saved trials